Changing the course of autoimmune disease

Inspired by patients. Driven to make an impact.

Aurinia’s Response to COVID-19

View

Latest News

November 20, 2020 • 12:00am EST

Aurinia Announces New Employment Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Read Press Release View All News

November 12, 2020 • 12:00am EST

Aurinia Pharmaceuticals to Present at the 2020 Jefferies Virtual London Healthcare Conference

Read Press Release View All News

November 10, 2020 • 12:00am EST

Aurinia Reports Third Quarter 2020 Financial Results and Recent Operational Highlights

Read Press Release View All News